TwinBeech Capital
VERA icon

TwinBeech Capital’s Vera Therapeutics VERA Stock Holding History

TwinBeech Capital’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$695K Sell
16,200
-5,500
-25% -$205K 0.13% 192
2026
Q1 		$873K Buy
21,700
+2,770
+15% +$119K 0.09% 281
2025
Q4 		$959K Buy
+18,930
New +$672K 0.07% 310
2025
Q2 		– Sell
-179,550
Closed -$4.31M – 993
2025
Q1 		$4.31M Buy
+179,550
New +$5.77M 0.08% 275
2024
Q3 		– Sell
-93,176
Closed -$3.37M – 909
2024
Q2 		$3.37M Buy
+93,176
New +$3.7M 0.07% 270

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Avoro Capital Advisors
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Deep Track Capital
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.6B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Sofinnova Investments
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

TwinBeech Capital's VERA Position: Q2 2026 in Review

TwinBeech Capital reduced its Vera Therapeutics (VERA) stake by 25% in Q2 2026, selling an estimated $205K and leaving 16,200 shares worth $695K. The position accounts for 0.13% of the portfolio, ranked #192.

TwinBeech Capital first reported a position in VERA in Q2 2024 and has held it in 5 quarters since. The position peaked at $4.31M in Q1 2025. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • TwinBeech Capital held 16,200 shares of Vera Therapeutics worth $695K as of Q2 2026.
  • TwinBeech Capital sold 5,500 Vera Therapeutics shares in Q2 2026, an estimated $205K.
  • Vera Therapeutics made up 0.13% of TwinBeech Capital's portfolio in Q2 2026, its #192 holding.
  • TwinBeech Capital first reported a position in Vera Therapeutics in Q2 2024 and has held it in 5 quarters since.
  • TwinBeech Capital's Vera Therapeutics position peaked at $4.31M in Q1 2025.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on TwinBeech Capital's 13F filing for Q2 2026, filed 14 Aug 2026.